/
QTRX
$3.19+$0.15 (+4.93%)live
Change$-50.12
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$143.8M
47M shares
52-week range
$2.15 – $8.77
16% from low
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NASDAQ
CS
P/S (TTM)
1.0
Quanterix Corporation Common Stock
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
www.quanterix.com- Employees
- 450
- IPO / List date
- Dec 7, 2017
- HQ
- BILLERICA, MA
Held by traders on TradeandTell
No one on the platform currently holds QTRX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 136,207 | $479.4K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded QTRX yet.
